rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
1977-2-16
|
pubmed:abstractText |
We have established or characterized six lines of human breast cancer maintained in long-term tissue culture for at least 1 year and have examined these lines for estrogen responsiveness. One of these cell lines, MCF-7, shows marked stimulation of macromolecular synthesis and cell division with physiological concentrations of estradiol. Antiestrogens are strongly inhibitory, and at concentrations greater than 3 X 10(-7) M they kill cells. Antiestrogen effects are prevented by simultaneous treatment with estradiol or reversed by addition of estradiol to cells incubated in antiestrogen. Responsive cell lines contain high-affinity specific estradiol receptors. Antiestrogens compete with estradiol for these receptors but have a lower apparent affinity for the receptor than estrogens. Stimulation of cells by estrogens is biphasic, with inhibition and cell death at concentrations of 17beta-estradiol or diethylstilbestrol exceeding 10(-7) M. Killing by high concentrations of estrogen is probably a nonspecific effect in that we observe this response with 17alpha-estradiol at equivalent concentrations and in the otherwise unresponsive cells that contain no estrogen receptor sites.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Diethylstilbestrol,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens,
http://linkedlifedata.com/resource/pubmed/chemical/Nitromifene,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0008-5472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4595-601
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1000504-Binding, Competitive,
pubmed-meshheading:1000504-Binding Sites,
pubmed-meshheading:1000504-Breast Neoplasms,
pubmed-meshheading:1000504-Cell Division,
pubmed-meshheading:1000504-Cell Line,
pubmed-meshheading:1000504-Cells, Cultured,
pubmed-meshheading:1000504-DNA, Neoplasm,
pubmed-meshheading:1000504-Diethylstilbestrol,
pubmed-meshheading:1000504-Dose-Response Relationship, Drug,
pubmed-meshheading:1000504-Estradiol,
pubmed-meshheading:1000504-Estrogens,
pubmed-meshheading:1000504-Female,
pubmed-meshheading:1000504-Humans,
pubmed-meshheading:1000504-Nitromifene,
pubmed-meshheading:1000504-RNA, Neoplasm,
pubmed-meshheading:1000504-Receptors, Estrogen,
pubmed-meshheading:1000504-Tamoxifen
|
pubmed:year |
1976
|
pubmed:articleTitle |
The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
|
pubmed:publicationType |
Journal Article
|